Session Detail


Session Title: The Emerging Role of Nanotechnology in Cancer Therapy
Session Type: Educational Session
Session Start/End Time: Saturday, Apr 02, 2011, 1:00 PM - 3:00 PM
Location: Room W311 A-D, Orange County Convention Center
CME Designation: CME-Designated
CME/CE Hours: 2
Session Description: Nanotechnology is a rapidly advancing discipline incorporating chemistry, materials science, physics and biology that has emerged as a potentially transformative paradigm to rationally design cancer medicines with improved therapeutic indices. Much of the excitement stems from the inherent versatility and customizable nature of nanoparticles, which can be multifunctionalized to incorporate targeting elements, a wide range of therapeutic cargo (drugs, siRNAs and peptides) and imaging agents. Moreover, nanotherapeutics can be specifically tailored to the molecular characteristics of tumors, thereby offering unprecedented opportunities for personalized medicine. Nevertheless, nanomedicines face a number of distinctive barriers to their clinical translation, including difficulties in achieving robust tumor targeting and/or penetration, systemic toxicity, and GMP production and regulatory challenges. This session will highlight recent progress in the design and evaluation of several novel nanotherapeutic platforms for cancer and explore their implications for bringing nanomedicines into the clinic.
Webcast: http://webcast.aacr.org/portal/s/2011annual/ED26
Presentations:
Chairperson
Vincent L. Cryns. Northwestern Univ. School of Medicine, Chicago, IL
Nanoscale design and translation of cancer therapeutics
Saturday, Apr 02, 2011, 1:00 PM - 1:25 PM
Vincent L. Cryns. Northwestern Univ. School of Medicine, Chicago, IL
Discussion
Saturday, Apr 02, 2011, 1:25 PM - 1:30 PM
.. .
Mechanistic insights in design of nanomedicine for cancer chemotherapy: a translational story
Saturday, Apr 02, 2011, 1:30 PM - 1:55 PM
Shiladitya Sengupta. Brigham & Women's Hospital, Cambridge, MA
Discussion
Saturday, Apr 02, 2011, 1:55 PM - 2:00 PM
.. .
Personalized cancer nanomedicine
Saturday, Apr 02, 2011, 2:00 PM - 2:25 PM
Mauro Ferrari. Houston, TX
Discussion
Saturday, Apr 02, 2011, 2:25 PM - 2:30 PM
.. .
Trials on systemic delivery of cancer therapeutics via targeted nanoparticles
Saturday, Apr 02, 2011, 2:30 PM - 2:55 PM
Esther H. Chang. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC
Discussion
Saturday, Apr 02, 2011, 2:55 PM - 3:00 PM
.. .